Abstract:Schizophrenia is a chronic debilitating psychiatric disorder affecting as many as 1% of the population worldwide. Unfortunately, its etiology and pathophysiology are poorly defined. Previous studies have shown that neuronal injury and microglia activation were observed in the schizophrenic patients. The present study aims to evaluate the role of neurons and microglia in ketamine-induced experimental schizophrenic model to further understand its pathophysiology. Firstly, ketamine was used to simulate the behavior abnormalities associated with schizophrenia. The effects of ketamine on mouse locomotor activity, Y-maze task, novel object recognition, and forced swimming test were studied. The results showed that ketamine (25, 50, and 100mg/kg i.p.) administered acutely or repeatedly (for 7days) can increase the locomotor number significantly. In Y-maze task, ketamine (25, 50, and 100mg/kg) impaired spontaneous alternation after both acute and repeated treatments. In novel object recognition test, acute or chronic ketamine treatment showed no significant effect on mouse exploratory preference behavior. In forced swimming test, repeated treatment of ketamine (100mg/kg) enhanced the immobility duration. Secondly, immunohistochemical method was used to study the changes of neurons and microglia. The results showed that acute treatment of ketamine (100mg/kg) had no effect on neurons in the prefrontal cortex or hippocampus (1, 3, 5, and 7days after the treatment). In contrast, repeated treatment of ketamine caused neuronal impairment in mouse hippocampus (3rd day, 5th day and 7th day after the final administration). The results of immunohistochemistry demonstrated that microglia in the prefrontal cortex and hippocampus were not affected after acute or repeated administration of ketamine. Finally, the neuronal impairment caused by repeated administration of ketamine was further investigated from the oxidative stress aspects. The results showed that repeated administration of ketamine increased nitric oxide (NO) and nitric oxide synthase (NOS) in prefrontal cortex, hippocampus and serum, while decreased SOD in hippocampus and serum. In summary, chronic ketamine treatment to mice successfully mimics the core behavioral deficits in schizophrenia. It is demonstrated for the first time that neuronal injury was associated with the chronic ketamine-induced experimental schizophrenic model, while microglial cells may play little role in this model. Oxidative stress may contribute to the significant neuronal injury in mouse brain induced by chronic ketamine treatment.

Ketamine Induces Neuronal Apoptosis and Cognitive Disorder Via Mir-199A-5p/hif-1α in Neonatal Rats

Repeated Administration of Ketamine Can Induce Hippocampal Neurodegeneration and Long-Term Cognitive Impairment Via the ROS/HIF-1α Pathway in Developing Rats

Repeated Ketamine Anesthesia during the Neonatal Period Impairs Hippocampal Neurogenesis and Long-Term Neurocognitive Function by Inhibiting Mfn2-Mediated Mitochondrial Fusion in Neural Stem Cells

Ketamine induces hippocampal apoptosis through a mechanism associated with the caspase-1 dependent pyroptosis.

Impaired synaptic plasticity and decreased excitability of hippocampal glutamatergic neurons mediated by BDNF downregulation contribute to cognitive dysfunction in mice induced by repeated neonatal exposure to ketamine

Effects of ketamine on the neurons apoptosis and NMDAR-2B expression in neonatal rats hippocampal CA3 area

Ketamine exerts dual effects on the apoptosis of primary cultured hippocampal neurons from fetal rats in vitro

Reactive Oxygen Species-mediated Loss of Phenotype of Parvalbumin Interneurons Contributes to Long-term Cognitive Impairments after Repeated Neonatal Ketamine Exposures

Adolescent Administration of Ketamine Impairs Excitatory Synapse Formation Onto Parvalbumin-Positive GABAergic Interneurons in Mouse Prefrontal Cortex

Mechanisms of Propofol Attenuation of Ketamine-Induced Neonatal Brain Injury

Ketamine Administered Pregnant Rats Impair Learning and Memory in Offspring Via the Creb Pathway

Effects of ketamine on the cognitive function and hippocampus synaptophysin expression in neonatal rats

Ketamine Exacerbates Cortical Neuroapoptosis under Hyperoxic Conditions by Upregulating Expression of the N-methyl-D-aspartate Receptor Subunit NR1 in the Developing Rat Brain

Long-term neurocognitive dysfunction in offspring via NGF/ ERK/CREB signaling pathway caused by ketamine exposure during the second trimester of pregnancy in rats

Acute ketamine induces hippocampal synaptic depression and spatial memory impairment through dopamine D1/D5 receptors

Effect of Ketamine Anesthesia on Cognitive Function and Immune Function in Young Rats.

Repeated Isoflurane Exposures of Neonatal Rats Contribute to Cognitive Dysfunction in Juvenile Animals: the Role of Mir-497 in Isoflurane-Induced Neurotoxicity

Retraction Note: Ketamine Exerts Neurotoxic Effects on the Offspring of Pregnant Rats Via the Wnt/β-catenin Pathway

Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice.

Ketamine administration causes cognitive impairment by destroying the circulation function of the glymphatic system

Neonatal Ketamine Exposure-Induced Cognitive Dysfunction Persists into Adulthood in Rats